Related Experiment Videos
Pharmaceutical development of anticancer agents derived from marine sources
1Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam. apbnu@siz.nl
Anti-Cancer Drugs
|January 6, 2001
Summary
Marine organisms offer promising anticancer agents. Developing effective pharmaceutical formulations is crucial for bringing these marine-derived cancer drugs from discovery to clinical application.
Area of Science:
- Marine biology
- Pharmacology
- Drug development
Background:
- Marine ecosystems are increasingly recognized as a rich source of novel anticancer compounds.
- Significant challenges exist in translating marine-derived drug candidates into clinical treatments.
- Key hurdles include ensuring a sustainable supply and developing viable pharmaceutical formulations.
Purpose of the Study:
- To review the general issues in pharmaceutical development for marine anticancer agents.
- To highlight the critical importance of formulation development for clinical utility.
- To illustrate these challenges using examples of marine-derived anticancer compounds.
Main Methods:
- Literature review focusing on pharmaceutical development and formulation of marine anticancer agents.
- Analysis of challenges in drug supply and formulation.
- Case studies of representative marine compounds.
Main Results:
- Successful clinical translation requires overcoming substantial pharmaceutical development hurdles.
- Formulation development is a critical bottleneck for marine-derived anticancer drugs.
- Sufficient compound supply and appropriate drug delivery systems are essential.
Conclusions:
- Marine natural products hold significant potential for cancer therapy.
- Addressing formulation and supply challenges is paramount for advancing marine anticancer agents.
- Further research into pharmaceutical development is vital for realizing the clinical benefits of marine-derived drugs.